相关实验视频

Updated: Sep 10, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

用前列腺特异性膜抗原 (PSMA) 产生人工智能的潜力:挑战和未来方向

Md Zobaer Islam1,2, Ergi Spiro3, Pew-Thian Yap1,2

  • 1Department of Radiology, University of North Carolina, Chapel Hill, NC, USA.

Medical review (2021)
|August 21, 2025
PubMed
概括

使用PSMA-PET扫描,可以解决前列腺癌 (PCa) 成像方面的挑战. 这项技术增强了图像分析,改善了PCa患者的诊断和预后.

关键词:
生成性人工智能分子成像;前列腺特异性膜抗原向的正子发射断层扫描

更多相关视频

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

236
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

665

相关概念视频

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.4K